MedPath

DyeVert Pilot Trial

Not Applicable
Completed
Conditions
Coronary Angiography
Interventions
Device: Coronary Angiography
Registration Number
NCT02606734
Lead Sponsor
Osprey Medical, Inc
Brief Summary

The purpose of this study is to evaluate the usability characteristics of DyeVert™ during normal clinical use and to understand the amount of contrast media (CM) diverted from the subject and saved over a total angiographic procedure.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
44
Inclusion Criteria
  1. The subject is indicated for a coronary angiogram or percutaneous coronary procedure
  2. The subject is ≥ 18 years of age
  3. The subject (or subject's legal representative) is willing and able to provide appropriate informed consent.
Exclusion Criteria
  1. Subject is undergoing a STEMI procedure
  2. The subject is female and currently pregnant
  3. In the investigator's opinion, the subject is not considered to be a suitable candidate

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Treatment ArmCoronary AngiographyAll subjects enrolled in the trial will use the DyeVert System.
Primary Outcome Measures
NameTimeMethod
Volume (Percentage) of Contrast Media (CM) Diverted (Saved) in a Total Procedure1 Day

The subject is exited from the study once they are discharged.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

University Hospital of Schleswig-Holstein

🇩🇪

Lübeck, Germany

Monash Health

🇦🇺

Clayton, Victoria, Australia

© Copyright 2025. All Rights Reserved by MedPath